trending Market Intelligence /marketintelligence/en/news-insights/trending/gJd5K89hZ6pvph4it5BNGA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Silk Road Medical shareholders price upsized secondary offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Silk Road Medical shareholders price upsized secondary offering

Silk Road Medical Inc. said certain shareholders priced their sale of 4.2 million common shares of the company at $39.50 per share.

The secondary offering was upsized from the previous offering size of 3.5 million common shares. The 30-day option for the underwriters to purchase additional shares was also upsized to 630,000 common shares from 525,000 common shares.

The offering is expected to close Aug. 13.

J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering, while BMO Capital Markets and Stifel are acting as co-managers.

Silk Road is a medical device company focused on reducing the risk of stroke.